An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability of Simufilam 100 mg Tablets in Participants with Mild to Moderate Alzheimer’s Disease

  • Darby, David (Primary Chief Investigator (PCI))
  • Cao, Ting (Project Manager)
  • Kyndt, Chris (Partner Investigator (PI))
  • Brodtmann, Amy (Partner Investigator (PI))
  • Zeimer, Henry (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date19/05/23 → 19/05/25

Keywords

  • Clinical trial
  • Alzheimer’s Disease
  • Simufilam